Featured Research

from universities, journals, and other organizations

Fungus-fighting drug may make mild flu meaner

Date:
November 21, 2013
Source:
Cell Press
Summary:
Mice given a drug commonly used in patients to fight systemic fungal infections more often succumb to what would otherwise be a mild case of the flu. The evidence shows that the drug called Amphotericin B, which has an estimated $330 million in sales around the world each year, can render a protein important for antiviral defense ineffective in both cells and mice.

Mice given a drug commonly used in patients to fight systemic fungal infections more often succumb to what would otherwise be a mild case of the flu. The evidence reported in the Cell Press journal Cell Reports on November 21st shows that the drug called Amphotericin B, which has an estimated $330 million in sales around the world each year, can render a protein important for antiviral defense ineffective in both cells and mice.

The findings suggest that patients receiving the antifungal therapy may be functionally immunocompromised and more vulnerable to influenza and other viral infections, the researchers said.

"Many critically ill cancer and bone marrow transplant patients are treated with Amphotericin B-based therapies each year," said Abraham Brass of the University of Massachusetts Medical School (UMMS). "Given these results in cells and mice, it may be worthwhile to consider that patients receiving, or who may receive, Amphotericin B-based therapies be appropriately vaccinated against influenza virus. Also, clinical consideration may be given to close monitoring of patients receiving Amphotericin B-based therapies for any symptoms suggestive of flu so that they might be considered for the early administration of an antiflu therapy."

The researchers showed that Amphotericin-B prevents the antiviral protein in cells known as IFITM3 from fending off influenza A virus.

"When we treated lung cancer cells with the antifungal drug, we saw the antiviral protection from IFITM3 pretty much disappear," explained Christopher Chin, co-first author, also from UMMS.

When researchers in Paul Kellam's group at the Wellcome Trust Sanger Institute exposed mice treated with Amphotericin-B to influenza A virus, the animals became very ill and lost more than 25 percent of their body weight. Those symptoms looked very similar to those in animals completely lacking the protective IFITM3 protein. Mice that had not been treated with Amphotericin-B experienced only a moderate illness and recovered fully, as expected. In effect, treatment with Amphotericin-B converted a mild illness for the mice into a life-threatening one.

"Sometimes a very useful drug can have unforeseen effects, and the more we can learn about such things, the better care we can provide," Brass said.

The new study should prompt further clinical research. For instance, he added, studies could be designed to monitor both the number and the severity of flu infections in patients receiving Amphotericin B-based therapies.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lin et al. Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-mediated Restriction. Cell Reports, November 2013

Cite This Page:

Cell Press. "Fungus-fighting drug may make mild flu meaner." ScienceDaily. ScienceDaily, 21 November 2013. <www.sciencedaily.com/releases/2013/11/131121125857.htm>.
Cell Press. (2013, November 21). Fungus-fighting drug may make mild flu meaner. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2013/11/131121125857.htm
Cell Press. "Fungus-fighting drug may make mild flu meaner." ScienceDaily. www.sciencedaily.com/releases/2013/11/131121125857.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins